The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery.
 
Nieves Martinez Chanza
No Relationships to Disclose
 
Anis Hamid
Honoraria - Bayer
Consulting or Advisory Role - MSD
 
Roberto Salgado
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
Research Funding - Merck; Puma Biotechnology
Travel, Accommodations, Expenses - Merck; Roche
 
Thomas Gevaert
No Relationships to Disclose
 
Marion Maetens
No Relationships to Disclose
 
Sandrine Rorive
No Relationships to Disclose
 
Philippe Georges Aftimos
Honoraria - Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Macrogenics; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pfizer; Roche Belgium
 
Spyridon Sideris
No Relationships to Disclose
 
Thierry Gil
No Relationships to Disclose
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Lilly
Research Funding - Bristol-Myers Squibb; MSD
 
Thierry Andre Roumeguere
No Relationships to Disclose